The Oncology Institute to Participate at Upcoming Investor Conferences
May 29 2024 - 8:00AM
The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest
value-based oncology practices in the country, today announced that
Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate
at the following investor conferences:
Jefferies Global Healthcare ConferenceDate: June 6th,
2024Fireside Chat: 9:00am Eastern TimeTOI Participant: Daniel
Virnich, M.D., MBA, Chief Executive OfficerLocation: New York City,
NY
Truist Securities Healthcare Disruptors & Digital Health
SummitDate: June 26th, 2024Panel: 1:00pm Eastern TimeTOI
Participant: Daniel Virnich, M.D., MBA, Chief Executive
OfficerLocation: New York City, NY
Interested investors and other parties may listen to
simultaneous webcasts of the presentations by logging onto the
Investor Relations section of the Company’s website at
https://investors.theoncologyinstitute.com/. The online replay will
be available for a limited time shortly following the call.
About The Oncology Institute, Inc.
Founded in 2007, The Oncology Institute, Inc. and its affiliates
(NASDAQ: TOI) is advancing oncology by delivering highly
specialized, value-based cancer care in the community setting. TOI
offers cutting-edge, evidence-based cancer care to a population of
more than 1.8 million patients including clinical trials,
transfusions, and other care delivery models traditionally
associated with the most advanced care delivery organizations. With
110+ employed clinicians and over 70 clinic locations and growing,
TOI is changing oncology for the better. For more information visit
www.theoncologyinstitute.com.
Contacts
InvestorsSolebury Strategic
Communicationsinvestors@theoncologyinstitute.com
Oncology Institute (NASDAQ:TOI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Oncology Institute (NASDAQ:TOI)
Historical Stock Chart
From Oct 2023 to Oct 2024